The committee that advises the California Division of Workers’ Compensation on evidence-based changes to the prescription drug formulary canceled its quarterly meeting in light of the COVID-19 pandemic.
The Pharmacy and Therapeutics Committee was scheduled to meet next Wednesday. The pandemic previously forced the committee to cancel its meeting that was scheduled for April 22.
Assembly Bill 1124, which ordered the DWC to implement a prescription drug formulary, also mandated the creation of the P&T Committee as an advisory body.
Although the committee will not meet in July as sch...
Comments